PACED Act

Summary

Preserving Access to Cost Effective Drugs Act or the PACED Act This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission. Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 7 March 2018

   Introduced

   Introduced in Senate

   Source: IntroReferral

2. 7 March 2018

   Introduced

   Read twice and referred to the Committee on the Judiciary.

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 7 March 2018 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 7 March 2018

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 7 March 2018

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 7 March 2018

  Open at official source

Sponsors

• Tom Cotton · R · Sponsor
• Sen. McCaskill, Claire [D-MO] · D · Sponsor
• Sen. Perdue, David [R-GA] · R · Sponsor
• Joni Ernst · R · Sponsor
• Sen. Toomey, Patrick [R-PA] · R · Sponsor
• · ssju00 · Standing

Related records

• related to → PACED Act